Carprox vet. (25 - 50 mg)
Active substance
ATC code
Species
Dogs.
Indications
Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post operative pain.
Dose to be administered and administration route
For oral administration.
An initial dose of 2 to 4 mg carprofen per kg bodyweight per day is recommended to be given as a single or in two equally divided doses. Subject to clinical response, the dose may be reduced after 7 days to 2 mg carprofen/kg bodyweight/day given as a single dose. To extend analgesic cover post-operatively, parenteral therapy with solution for injection may be followed with tablets at 4 mg/kg/day for up to 5 days.
Duration of treatment will be dependent upon the response seen, but the dog’s condition should be re-appraised by the veterinary surgeon after 14 days therapy.
Adverse reactions
Typical undesirable effects associated with NSAIDs such as vomiting, soft faeces/diarrhoea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought.
As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events.
Similar products
Showing 4 of 4 results
Carprox vet. (25 - 50 mg)
Carprox vet. (25 - 50 mg)
Carprox vet. (25 - 50 mg)
